Clinical Trial Update: Conversion to Antipsychotic Monotherapy [NA]

View source ↗

Summary

The clinical trial NCT01368458 evaluating conversion to antipsychotic monotherapy in schizophrenia and schizoaffective disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: TERMINATED